Academics & Research

Newsroom

"Huntsman Cancer Institute," News

    Huntsman Cancer Institute One of the Top in the Nation; University of Utah Hospital Best in Utah, according to latest U.S. News & World Report Rankings
    Education, Clinical, Research, Health Care Transformation
    Aug 02, 2016

    Huntsman Cancer Institute One of the Top in the Nation; University of Utah Hospital Best in Utah, according to latest U.S. News & World Report Rankings

    Huntsman Cancer Institute,

    SALT LAKE CITY—U.S. News & World Report has released its 2016-2017 Best Hospital Rankings and named University of Utah’s Huntsman Cancer Institute (HCI) one of the top 50 cancer hospitals in the country. “We are extremely pleased to be recognized by U.S. News & World Report as one of the nation’s top cancer hospitals,” said Mary Beckerle, CEO and director of HCI. “Cancer touches the lives of everyone, and this recognition reflects our efforts to relieve the burden of this disease on our patients and their families through excellent patient care and robust scientific research. We are motivated by the idea that it is possible to defeat cancer.”... Read More

    Better health before surgery leads to better outcomes
    Clinical, Education, Health Care Transformation, Research
    Aug 01, 2016

    Better health before surgery leads to better outcomes

    Huntsman Cancer Institute,

    Surgery is part of cancer treatment plans in many cases. While surgery is an important part of treatment, recovery from surgery has a major impact on overall health. Strong for Surgery is a program that focuses on making small changes in health before surgery. Making these changes, even just before surgery, can make a big difference in recovery.... Read More

    Therapy on four legs
    Health Care Transformation, Clinical, Research, Education
    Aug 01, 2016

    Therapy on four legs

    Huntsman Cancer Institute,

    Every week, a special visitor appears at Huntsman Cancer Institute (HCI). His job? To cheer up patients fighting cancer and their family members. His name is Misio, and he’s a therapy dog with Intermountain Therapy Animals. Kathy McNulty, a volunteer with the organization, is Misio’s escort. Kathy says Misio has only been coming to HCI for a few months, but she can already see the difference he’s making for patients and their families. “Over and over, I’ve seen tears turn to smiles,” she says. “Misio takes their minds off the procedures.”... Read More

    Chemoprevention for People at High Risk
    Clinical, Research, Health Care Transformation, Education
    Jul 31, 2016

    Chemoprevention for People at High Risk

    Huntsman Cancer Institute,

    Individuals with familial adenomatous polyposis (FAP) have a nearly 100 percent chance of developing colon cancer and often undergo surgery to remove the colon so cancer can’t develop there. A new medication being tested in a clinical trial lead by Jewel Samadder, MD, has shown promising results. The first round of testing shows that in less than six months, half of the patients who received medication saw a nearly 70% regression of polyps. For some, polyps disappeared completely.... Read More

    Why Do Elephants Almost Never Get Cancer?
    Clinical, Health Care Transformation, Education, Research
    Jul 31, 2016

    Why Do Elephants Almost Never Get Cancer?

    Huntsman Cancer Institute,

    P53 – one gene that may hold the key. Humans have two copies, but some people are missing a copy. For individuals with only one working copy of P53, their lifetime risk of cancer is nearly 100 percent. Elephants, after 55 million years of evolution, have 40 copies of the P53 gene. Those extra copies protect elephant’s cells from cancer by eliminating cells that develops any type of mutation that could go on to become cancer.... Read More

    Education, Clinical, Health Care Transformation, Research
    Jul 25, 2016

    NantHealth and University of Utah Establish Heritage 1K Project to Discover Genetic Causes of 25 Rare and Common Diseases

    Huntsman Cancer Institute,

    NantHealth, Inc., (Nasdaq: NH), a leading next-generation, evidence-based, personalized healthcare company, today announced that it has partnered with the University of Utah in analyzing the entire genomic profiles of at least 1,000 individuals who have a history of rare and life-threatening diseases and conditions in their respective families. The landmark project will focus on researching the genetic causes of 25 conditions, including, breast, colon, ovarian, and prostate cancers, amyotrophic lateral sclerosis (ALS), chronic lymphocytic leukemia, autism, preterm birth, epilepsy, and other hereditary conditions. Genomic sequencing will be conducted with unique, comprehensive molecular tests offered by NantHealth. NantHealth’s genomic sequencing platform integrates whole genome (DNA) sequencing, and RNA sequencing. By carrying out this extensive testing, including analysis of germline and somatic samples, University of Utah and NantOmics researchers will be able to explore the underlying genetic causes of certain conditions and diseases at the cellular level.... Read More

    Health Care Transformation, Clinical, Research, Education
    Jul 22, 2016

    Hope for a cancer-free future: chemoprevention for people at high risk

    Huntsman Cancer Institute,

    Kathy and her niece, Rhonda, regularly make the trip from their small town in Illinois, to Salt Lake City. They don’t come to see family and friends or to cheer for the University of Utah. They come to Huntsman Cancer Institute (HCI) to be tested for polyps in their small intestines. Kathy and Rhonda both have familial adenomatous polyposis (FAP), an inherited genetic disease. FAP causes hundreds of polyps to form throughout the small and large intestines. Any polyp in the intestine has the potential to become cancer. With so many polyps, people with FAP have a nearly 100-percent chance of developing colon cancer. Patients with FAP often undergo surgery to remove the colon so cancer can’t develop there.... Read More

    Education, Research, Health Care Transformation, Clinical
    Jul 21, 2016

    St. Baldrick's Foundation Grants More Than $22 Million For Lifesaving Childhood Cancer Research

    Huntsman Cancer Institute,

    LOS ANGELES, July 21, 2016 /PRNewswire/ -- The St. Baldrick's Foundation, a volunteer-powered charity dedicated to raising money for childhood cancer research, is proud to announce that it has awarded 79 new grants totaling more than $22 million to support the best and brightest researchers looking for cures and better treatments for all childhood cancers.... Read More

    Madison Memorial teams up with Huntsman Cancer Institute on clinic
    Education, Research, Health Care Transformation, Clinical
    Jul 19, 2016

    Madison Memorial teams up with Huntsman Cancer Institute on clinic

    Huntsman Cancer Institute,

    Madison Memorial Hospital and the the Huntsman Cancer Institute have teamed up to better provide cancer patients with convenient and closer services. The goal of the project is to give local patients an easier commute, instead of traveling miles out of town for cancer services. CEO of Madison Memorial Hospital Rachel Gonzales said the last thing you want to do when your sick is think about the burden of traveling far. "You're not feeling well, you're stress you're afraid. You just received the scariest diagnosis of your life. And you're having to travel and leave your family often. So that travel time just adds more stress," Gonzales said. After all, the treatment requires temporarily increasing levels of certain sex hormones to five or 10 times the normal. Two of those hormones, estrogen and progesterone, can affect the course of certain kinds of breast cancer.... Read More

    Education, Clinical, Health Care Transformation, Research
    Jul 19, 2016

    I.V.F. Does Not Raise Breast Cancer Risk, Study Shows

    Huntsman Cancer Institute,

    Women undergoing in vitro fertilization have long worried that the procedure could raise their risk for breast cancer. After all, the treatment requires temporarily increasing levels of certain sex hormones to five or 10 times the normal. Two of those hormones, estrogen and progesterone, can affect the course of certain kinds of breast cancer.... Read More

    Clinical, Education, Health Care Transformation, Research
    Jul 19, 2016

    Cases of Aggressive Prostate Cancer on the Rise, Research Finds

    Huntsman Cancer Institute,

    Cases of aggressive prostate cancer appear to be on the rise, researchers reported Tuesday. The good news is it's still rare for prostate cancer to spread. Just 3 percent of cases have already started spreading when men are diagnosed and prostate cancer overall has not become more common, the team found. And the American Cancer Society strongly questioned the findings and the methods used to get them.... Read More

    Health Care Transformation, Education, Clinical, Research
    Jul 19, 2016

    Physician-assisted suicide, euthanasia: increasingly legal but still rare

    Huntsman Cancer Institute,

    Legalized euthanasia and physician-assisted suicide are mainly used by patients with cancer, but remain rare, according to a new analysis of such programs. In the last year alone, California has legalized physician-assisted suicide, Canada legalized both physician-assisted suicide and euthanasia, and Colombia performed its first legal euthanasia, said John Urwin, a study author from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. "In order to inform current debates, it's imperative to understand current laws and practices."... Read More

    Toward True Health: Fight cancer with good nutrition
    Research, Clinical, Education, Health Care Transformation
    Jul 18, 2016

    Toward True Health: Fight cancer with good nutrition

    Huntsman Cancer Institute,

    Question: With so many people affected by cancer, why is there so little information about the role of nutrition in cancer care? Sugar specifically? Answer: “It puzzles me why the simple concept ‘sugar feeds cancer’ can be so dramatically overlooked as part of a comprehensive cancer treatment plan” writes registered dietician Patrick Quillin, former director of nutrition for Cancer Treatment Centers of America in Tulsa, Okla. (Nutrition Science News, April 2000).... Read More

    Research, Health Care Transformation, Clinical, Education
    Jul 15, 2016

    Researchers identify new drug target for treating children with CNS-PNET

    Huntsman Cancer Institute,

    Primitive neuroectodermal tumors (PNETs) are the largest group of malignant brain tumors in children. They can arise from the brain's cerebellum or, more rarely, from tissue located throughout the central nervous system (CNS). Little is known about how CNS-PNETs develop, although these tumors are more aggressive than other PNETs and have an overall survival rate of only about 20 percent. In a new study, researchers for the first time have identified a possible target for a new CNS-PNET therapy.... Read More

    Clinical, Research, Education, Health Care Transformation
    Jul 15, 2016

    First Drug Target Identified for Children with Rare Type of Brain Tumor

    Huntsman Cancer Institute,

    Primitive neuroectodermal tumors (PNETs) are the largest group of malignant brain tumors in children. They can arise from the brain's cerebellum or, more rarely, from tissue located throughout the central nervous system (CNS). Little is known about how CNS-PNETs develop, although these tumors are more aggressive than other PNETs and have an overall survival rate of only about 20 percent. In a new study, researchers for the first time have identified a possible target for a new CNS-PNET therapy.... Read More

    Navigating Through Cancer
    Health Care Transformation, Clinical, Education, Research
    Jul 15, 2016

    Navigating Through Cancer

    Huntsman Cancer Institute,

    Eduardo Ayala was 17 years old when he was diagnosed with testicular cancer. He is fluent in English and Spanish, but his parents speak only Spanish. Eduardo and his family came to HCI from Nevada for his treatments. It is one of the five Mountain West states at the core of HCI’s service area. Cancer has a language all its own and it’s that much harder if English is not your first language. That’s where Guadalupe Tovar, a health educator and patient navigator at Huntsman Cancer Institute (HCI), comes in. She helps Hispanic families navigate their cancer care.... Read More

    Huntsman Cancer Institute Investigator Receives Leadership Award from the National Cancer Institute
    Research, Education, Health Care Transformation
    Jul 13, 2016

    Huntsman Cancer Institute Investigator Receives Leadership Award from the National Cancer Institute

    Huntsman Cancer Institute,

    The National Cancer Institute’s (NCI) Cancer Clinical Investigator Team Leadership Awards recognize and support outstanding clinical investigators at NCI-Designated Cancer Centers who participate extensively in NCI- funded collaborative clinical trials and whose leadership, participation, and activities promote a culture of successful clinical research. Established in 2009, the awards are intended to help retain investigators in academic clinical research careers. This year, 13 investigators nationwide, including Theresa Werner, MD, Huntsman Cancer Institute (HCI) investigator and University of Utah assistant professor of medicine have received the award.... Read More

    Health Care Transformation, Clinical, Education, Research
    Jul 12, 2016

    Drug Combo Reduces Duodenal Polyp Development

    Huntsman Cancer Institute,

    Treatment with a two-drug therapy of sulindac and erlotinib reduces the development of precancerous duodenal polyps in patients with familial adenomatous polyposis (FAP), according to a new study presented at the 2016 annual meeting of the American Association for Cancer Research (AACR) and published in Journal of the American Medical Association... Read More